Baysient
Healthcare Software · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8814 Tropical Ct, Fort Myers, Florida, 3...Phone Number
(800) 340-5377Website
www.baysient.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Baysient
Baysient develops cloud-based software designed to facilitate individualized dosing of anti-inflammatory monoclonal antibodies (MAbs) to enhance patient outcomes in inflammatory diseases such as IBD. Their innovative iDose software employs Bayesian models, routine lab results, and demographic data to assist physicians in determining precise dosing tailored to specific target trough levels. The platform aims to streamline the dosing process, making it quick and easy for healthcare professionals to implement personalized treatment plans. Baysient's services are intended for healthcare providers looking to improve therapeutic drug monitoring and patient care.Explore more
Baysient Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Baysient your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Baysient recently announced quarterly report
Product Launch: Get notified when Baysient launches new products
Congratulate Masked Content for being promoted to Masked Content at Baysient
Click to see if Baysient had a recent Job posting/layoffs
Baysient, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Baysient has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Baysient has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Baysient is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Baysient as Masked Content
Find 2 more new buyers
Compare Similar Companies to Baysient
Compare insights from companies similar to Baysient, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Baysient is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Baysient is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Baysient.
Baysient Tech Stack
A closer look at the technologies used by Baysient
Baysient News & Media
Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics
TuMinimize™ enables oncologists to deliver optimal drug dosing for each patient FORT MYERS, Fla., June 18, 2024 /PRNewswire/ -- Baysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed...Baysient Launches Digital TDM App for Fast, Personalized Infliximab Dosing
FORT MYERS, Fla., June 29, 2021 /PRNewswire/ -- Baysient LLC announces the release of T3 Time To Target, a new web-based application specifically for simple precision dosing of Infliximab. With its elegant and user-friendly interface, this transformative nomogram app uses real patient...Digital Health Company Baysient Announces CDS/HCEI Software to Reduce Healthcare Cost in the Biosimilar Market
FORT MYERS, Fla., Feb. 28, 2020 /PRNewswire/ -- Baysient® LLC's founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics and Precision Medicine in IBD at...Digital Health Company Baysient Announces CDS/HCEI Software to Reduce Healthcare Cost in the Biosimilar Market
Baysient® LLC's founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics and Precision Medicine in IBD at Canadian Digestive Disease Week (CDDW), February 28 – March 1. The presentation will include results from a 12-month clinical validation study (NCT02453776) demonstrating (p = 0.017) the potential to reduce "switching" from lower cost infliximab to more expensive bi
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Baysient
Sign Up For FreeTo access detailed company insights
Baysient develops cloud-based software designed to facilitate individualized dosing of anti-inflammatory monoclonal antibodies (MAbs) to enhance patient outcomes in inflammatory diseases such as IBD. Their innovative iDose software employs Bayesian models, routine lab results, and demographic data to assist physicians in determining precise dosing... Read More
